Scpharmaceuticals Correlations
| SCPHDelisted Stock | USD 5.67 0.01 0.18% |
The current 90-days correlation between Scpharmaceuticals and Climb Bio is 0.06 (i.e., Significant diversification). The correlation of Scpharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Scpharmaceuticals Correlation With Market
Poor diversification
The correlation between Scpharmaceuticals and DJI is 0.72 (i.e., Poor diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Scpharmaceuticals and DJI in the same portfolio, assuming nothing else is changed.
Scpharmaceuticals |
Moving together with Scpharmaceuticals Stock
| 0.67 | GS | Goldman Sachs Group | PairCorr |
| 0.61 | NTZ | Natuzzi SpA | PairCorr |
| 0.71 | SLSR | Solaris Resources | PairCorr |
| 0.65 | CYD | China Yuchai Interna Earnings Call This Week | PairCorr |
| 0.72 | GRBK | Green Brick Partners Earnings Call This Week | PairCorr |
| 0.71 | EMMA | Emmaus Life Sciences | PairCorr |
| 0.72 | CGECF | Cogeco Inc | PairCorr |
| 0.73 | USPH | US Physicalrapy | PairCorr |
| 0.61 | TORO | Toro | PairCorr |
| 0.77 | INTC | Intel | PairCorr |
| 0.62 | EXAS | EXACT Sciences Sell-off Trend | PairCorr |
| 0.63 | YLLXF | Yellow Cake plc | PairCorr |
| 0.64 | CAMZF | Camino Minerals | PairCorr |
| 0.77 | FRSB | First Resource Bank | PairCorr |
Moving against Scpharmaceuticals Stock
| 0.67 | TRNR | Interactive Strength | PairCorr |
| 0.63 | NIVF | NewGenIvf Group | PairCorr |
| 0.52 | APVO | Aptevo Therapeutics | PairCorr |
| 0.46 | BRK-A | Berkshire Hathaway Earnings Call Today | PairCorr |
Related Correlations Analysis
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Scpharmaceuticals Stock performing well and Scpharmaceuticals Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Scpharmaceuticals' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| CLYM | 6.43 | 1.85 | 0.33 | 1.08 | 5.13 | 16.99 | 42.56 | |||
| INZY | 8.04 | 3.70 | 0.60 | (1.02) | 3.27 | 10.42 | 179.17 | |||
| CKPT | 2.14 | 0.77 | 0.26 | 0.77 | 1.42 | 2.33 | 62.14 | |||
| THRD | 0.29 | 0.06 | (0.04) | (1.12) | 0.00 | 0.58 | 3.41 | |||
| VIGL | 7.50 | 3.81 | 0.81 | (1.02) | 1.63 | 5.09 | 241.38 | |||
| ORTX | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| SPPI | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| LAB | 2.97 | (0.18) | 0.00 | (0.04) | 0.00 | 7.81 | 27.04 | |||
| TSVT | 3.27 | 1.27 | 0.47 | 0.60 | 1.06 | 6.69 | 78.00 | |||
| SLRN | 3.22 | 0.35 | 0.02 | (0.08) | 4.22 | 5.85 | 35.54 |
Scpharmaceuticals Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Scpharmaceuticals stock to make a market-neutral strategy. Peer analysis of Scpharmaceuticals could also be used in its relative valuation, which is a method of valuing Scpharmaceuticals by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Scpharmaceuticals Corporate Management
| John PharmD | Senior Affairs | Profile | |
| Rachael Nokes | Principal Accounting Officer | Profile | |
| Katherine Taudvin | Director Relations | Profile | |
| Michael Hassman | Senior Operations | Profile | |
| Steve Parsons | Senior Commercial | Profile |
Still Interested in Scpharmaceuticals?
Investing in delisted delisted stocks can be risky, as the stock is no longer traded on a public exchange and can therefore be difficult to sell. Delisting typically occurs when a company has failed to meet exchange requirements or has been acquired. Before investing, it's important to thoroughly research the company, including its financial health and prospects for the future, as well as the reasons for its delisting. Additionally, it may be difficult to find accurate and up-to-date information on the company and its stock.